Search research articles
Contact Us
Filters
Showing results (321-330 of 644) with videos related to
Page
of 65
Sort By:
Gynecologic Oncology
|
October 1, 1995
Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody
J Deshane, G Cabrera, J E Grim, et al.
Hepatology (Baltimore, Md.)
|
November 1, 1994
Diurnal fluctuations of portal and systemic hemodynamic parameters in patients with cirrhosis
D Alvarez, D Golombek, P Lopez, et al.
Gynecologic Oncology
|
December 9, 2015
Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer
Kenneth H Kim, Danijela Jelovac, Deborah K Armstrong, et al.
Nature Communications
|
April 27, 2026
Quantitative live imaging reveals PRICKLE1 controls junctional neural tube morphogenesis independent of Planar Cell Polarity
Jian Xiong Wang, Yanina D Alvarez, Siew Zhuan Tan, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 1, 1996
Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma
M E Rosenfeld, M Wang, G P Siegal, et al.
European Journal of Medicinal Chemistry
|
June 9, 2014
Synthesis and biological evaluation of salpichrolide analogs as antiestrogenic agents
Juan M Sonego, Ezequiel M Rivero, Lucía Gargiulo, et al.
Gynecologic Oncology
|
January 15, 1999
A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group study
L G Feun, J A Blessing, F J Major, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 26, 2012
The effect of the APPRISE mandate on use of erythropoiesis-stimulating agents and transfusion rates in patients with ovarian cancer receiving chemotherapy
Jonathan D Boone, Janelle M Fauci, Christy L Walters, et al.
Gynecologic Oncology
|
March 1, 1997
Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy
J Deshane, G P Siegal, M Wang, et al.
Archives of Biochemistry and Biophysics
|
June 24, 2019
A conformational switch balances viral RNA accessibility and protection in a nucleocapsid ring model
D Alvarez Paggi, S A Esperante, M Salgueiro, et al.
Page
of 65
Search research articles
Search
Showing results (321-330 of 644) with videos related to
Sort By:
Page
of 65
Gynecologic Oncology
|
October 1, 1995
Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody
J Deshane, G Cabrera, J E Grim, et al.
Hepatology (Baltimore, Md.)
|
November 1, 1994
Diurnal fluctuations of portal and systemic hemodynamic parameters in patients with cirrhosis
D Alvarez, D Golombek, P Lopez, et al.
Gynecologic Oncology
|
December 9, 2015
Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer
Kenneth H Kim, Danijela Jelovac, Deborah K Armstrong, et al.
Nature Communications
|
April 27, 2026
Quantitative live imaging reveals PRICKLE1 controls junctional neural tube morphogenesis independent of Planar Cell Polarity
Jian Xiong Wang, Yanina D Alvarez, Siew Zhuan Tan, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 1, 1996
Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma
M E Rosenfeld, M Wang, G P Siegal, et al.
European Journal of Medicinal Chemistry
|
June 9, 2014
Synthesis and biological evaluation of salpichrolide analogs as antiestrogenic agents
Juan M Sonego, Ezequiel M Rivero, Lucía Gargiulo, et al.
Gynecologic Oncology
|
January 15, 1999
A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group study
L G Feun, J A Blessing, F J Major, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 26, 2012
The effect of the APPRISE mandate on use of erythropoiesis-stimulating agents and transfusion rates in patients with ovarian cancer receiving chemotherapy
Jonathan D Boone, Janelle M Fauci, Christy L Walters, et al.
Gynecologic Oncology
|
March 1, 1997
Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy
J Deshane, G P Siegal, M Wang, et al.
Archives of Biochemistry and Biophysics
|
June 24, 2019
A conformational switch balances viral RNA accessibility and protection in a nucleocapsid ring model
D Alvarez Paggi, S A Esperante, M Salgueiro, et al.
Page
of 65